Part II: Chemotherapy for epithelial ovarian cancer-treatment of rcurrent disease
M Harries, M Gore - The lancet oncology, 2002 - thelancet.com
For women with advanced ovarian cancer, rates of response to first-line chemotherapy are
high but most patients have relapses and become candidates for further chemotherapy …
high but most patients have relapses and become candidates for further chemotherapy …
Part II: Chemotherapy for epithelial ovarian cancer-treatment of rcurrent disease
M Harries, M Gore - The Lancet Oncology, 2002 - infona.pl
For women with advanced ovarian cancer, rates of response to first-line chemotherapy are
high but most patients have relapses and become candidates for further chemotherapy …
high but most patients have relapses and become candidates for further chemotherapy …
Part II: chemotherapy for epithelial ovarian cancer-treatment of recurrent disease.
M Harries, M Gore - The Lancet. Oncology, 2002 - europepmc.org
For women with advanced ovarian cancer, rates of response to first-line chemotherapy are
high but most patients have relapses and become candidates for further chemotherapy …
high but most patients have relapses and become candidates for further chemotherapy …
[引用][C] Part II: chemotherapy for epithelial ovarian cancer-treatment of recurrent disease
M HARRIES - Lancet Oncol, 2002 - cir.nii.ac.jp
Part II: chemotherapy for epithelial ovarian cancer-treatment of recurrent disease
M Harries, M Gore - The Lancet. Oncology, 2002 - pubmed.ncbi.nlm.nih.gov
For women with advanced ovarian cancer, rates of response to first-line chemotherapy are
high but most patients have relapses and become candidates for further chemotherapy …
high but most patients have relapses and become candidates for further chemotherapy …
Part II: Chemotherapy for epithelial ovarian cancer-treatment of rcurrent disease
M Harries, M Gore - The Lancet Oncology, 2002 - Elsevier
For women with advanced ovarian cancer, rates of response to first-line chemotherapy are
high but most patients have relapses and become candidates for further chemotherapy …
high but most patients have relapses and become candidates for further chemotherapy …
Part II: Chemotherapy for epithelial ovarian cancer-treatment of rcurrent disease
M Harries, M Gore - The Lancet Oncology, 2002 - thelancet.com
For women with advanced ovarian cancer, rates of response to first-line chemotherapy are
high but most patients have relapses and become candidates for further chemotherapy …
high but most patients have relapses and become candidates for further chemotherapy …
[引用][C] Part II: chemotherapy for epithelial ovarian cancer-treatment of recurrent disease
M HARRIES - Lancet Oncol, 2002 - cir.nii.ac.jp